Trademark: 86904098
Status Date
Monday, April 29, 2019
Filing Date
Wednesday, February 10, 2016
Published for Opposition
Tuesday, July 31, 2018
Abandoned Date
Monday, April 29, 2019
3 Artificial fingernails for medical use
5 Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of dermatological disorders, namely, dermatitis, skin pigmentation diseases and eczema; pharmaceutical preparations for the treatment of hematological disorders, namely, anemia, leukemia and thrombocytosis; pharmaceutical preparations for the treatment of renal disorders, namely, kidney stones, renal failure and nephritis; pharmaceutical preparations for the treatment of endocrine disorders, namely, Addison's disease, diabetes, Cushing's syndrome, thyroiditis; Medicated powders, medicated talcum powders, medicated creams, medicated lotions, medicated gels, medicated foundation and medicated lip balm for the treatment of dermatitis, psoriasis, eczema, fungal infections, sunburns, cancer and skin infections; glues for medical use; medical and wound dressings; dressing for the treatment of dermatological disorders, cancer and skin infections
9 Mobile applications for reporting physical and psychological incidents, including disease conditions
10 (Based on Intent to Use) Medical apparatus and instruments, namely, medical devices for applying pharmaceutical preparations and for introducing pharmaceutical preparations into the human body, namely, latex gloves, medical spatulas, syringes, needles, inhalers; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems, namely, nasal sprayers, ear drops, eye drops, infusion pumps, hypodermic syringes; medical devices, namely, devices for measuring body surface area affected by disease
35 Data processing services
38 Transmission of information through mobile applications and websites; Electronic transmission of data
42 Providing quality assurance and quality improvement services in the field of healthcare; pharmaceutical research services; medical research services in the field of cancer and dermatological, hematological, renal and endocrine disorders; Providing online non-downloadable software applications containing information on the use of pharmaceutical products and for calculating use of medicine
44 Providing medical information, consultancy and advisory services; medical and pharmaceutical consultation; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical counseling; medical services, including, medical care in the field of cancer and dermatological, hematological, renal and endocrine disorders; planning of medical treatment programs for the treatment of cancer and dermatological, hematological, renal and endocrine disorders; providing information and advice in the fields of cancer and dermatological, hematological, renal and endocrine disorders; providing a web site featuring medical information; hygienic and beauty care
Apr 29, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 29, 2019
Abandonment - No Use Statement Filed
Sep 25, 2018
Noa E-Mailed - Sou Required From Applicant
Jul 31, 2018
Official Gazette Publication Confirmation E-Mailed
Jul 31, 2018
Published For Opposition
Jul 11, 2018
Notification Of Notice Of Publication E-Mailed
Jun 26, 2018
Law Office Publication Review Completed
Jun 20, 2018
Exparte Appeal Terminated
Jun 19, 2018
Approved For Pub - Principal Register
Jun 19, 2018
Examiner's Amendment Entered
Jun 19, 2018
Notification Of Examiners Amendment E-Mailed
Jun 19, 2018
Examiners Amendment E-Mailed
Jun 19, 2018
Examiners Amendment -Written
Jun 19, 2018
Official Gazette Publication Confirmation E-Mailed
Jun 11, 2018
Previous Allowance Count Withdrawn
May 30, 2018
Withdrawn From Pub - Og Review Query
May 30, 2018
Notification Of Notice Of Publication E-Mailed
May 10, 2018
Approved For Pub - Principal Register
Apr 12, 2018
Teas/Email Correspondence Entered
Apr 12, 2018
Correspondence Received In Law Office
Apr 10, 2018
Teas Response To Suspension Inquiry Received
Dec 14, 2017
Notification Of Letter Of Suspension E-Mailed
Dec 14, 2017
Letter Of Suspension E-Mailed
Dec 14, 2017
Suspension Letter Written
Oct 31, 2017
Teas/Email Correspondence Entered
Oct 31, 2017
Correspondence Received In Law Office
Oct 16, 2017
Teas Response To Office Action Received
May 31, 2017
Notification Of Non-Final Action E-Mailed
May 31, 2017
Non-Final Action E-Mailed
May 31, 2017
Non-Final Action Written
May 26, 2017
Teas/Email Correspondence Entered
May 26, 2017
Correspondence Received In Law Office
May 22, 2017
Assigned To Lie
May 1, 2017
Teas Request For Reconsideration Received
May 1, 2017
Ex Parte Appeal-Instituted
May 1, 2017
Jurisdiction Restored To Examining Attorney
May 1, 2017
Exparte Appeal Received At Ttab
Nov 1, 2016
Notification Of Final Refusal Emailed
Nov 1, 2016
Final Refusal E-Mailed
Nov 1, 2016
Final Refusal Written
Oct 1, 2016
Teas/Email Correspondence Entered
Sep 30, 2016
Correspondence Received In Law Office
Sep 30, 2016
Teas Response To Office Action Received
May 26, 2016
Notification Of Non-Final Action E-Mailed
May 26, 2016
Non-Final Action E-Mailed
May 26, 2016
Non-Final Action Written
May 25, 2016
Assigned To Examiner
Feb 17, 2016
New Application Office Supplied Data Entered In Tram
Feb 13, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
